Chronic ingestion of flavan–3–ols and isoflavones reduces CVD risk biomarkers in medicated postmenopausal women with type 2 diabetes: a one year double–blind randomised controlled trial.

by Ketan Dhatariya | Sep 30, 2011 | 2011, Abstracts

Curtis PJ, Sampson MJ, Potter J, Dhatariya K, Rimm EB, Kroon PA, Cassidy A.

5th International Conference on Polyphenols and Health. Barcelona 2011

Viewing the Paper

Please Note:

To view the paper please click on the image. It will then open directly in your browser. Alternatively, you can right click on the image and select 'Save linked file as' to download the PDF.
To download the latest Adobe PDF viewer please click here.

PROFESSOR KETAN DHATARIYA

Consultant in Diabetes, Endocrinology & General Medicine

Chronic ingestion of flavan–3–ols and isoflavones reduces CVD risk biomarkers in medicated postmenopausal women with type 2 diabetes: a one year double–blind randomised controlled trial.

Recent Posts

Viewing the Paper

You have Successfully Subscribed!